Methotrexate Response (MTHFR)

See Cepmed’s Personalized Medicine Portal for more information about this test

Read More

Select your province to learn about access to testing & services in your area.

Overview

Methotrexate is a drug used to treat cancers and inflammatory diseases including rheumatoid arthritis, psoriasis, multiple sclerosis and Crohn’s disease. Some individuals are more sensitive to this drug and at high risk of toxicity, particularily certain Asian populations. Genetic testing can aid in identifying people with a high risk of toxicity when taking methotrexate. Follow the Read More button above to learn more.

Currently, this type of genetic testing is not readily available in Canada. Discuss this test with your physician to see if it could be beneficial for you.

Public Providers

Resources

Private Laboratories

*U.S. laboratories listed are certified by Centers for Medicare & Medicaid Service (CMS) CLIA Program

Overview

Methotrexate is a drug used to treat cancers and inflammatory diseases including rheumatoid arthritis, psoriasis, multiple sclerosis and Crohn’s disease. Some individuals are more sensitive to this drug and at high risk of toxicity, particularily certain Asian populations. Genetic testing can aid in identifying people with a high risk of toxicity when taking methotrexate. Follow the Read More button above to learn more.

Currently, this type of genetic testing is not readily available in Canada. Discuss this test with your physician to see if it could be beneficial for you.

Public Providers

Resources

Private Laboratories

*U.S. laboratories listed are certified by Centers for Medicare & Medicaid Service (CMS) CLIA Program

Overview

Methotrexate is a drug used to treat cancers and inflammatory diseases including rheumatoid arthritis, psoriasis, multiple sclerosis and Crohn’s disease. Some individuals are more sensitive to this drug and at high risk of toxicity, particularily certain Asian populations. Genetic testing can aid in identifying people with a high risk of toxicity when taking methotrexate. Follow the Read More button above to learn more.

Currently, this type of genetic testing is not readily available in Canada. Discuss this test with your physician to see if it could be beneficial for you.

Public Providers

Private Laboratories

*U.S. laboratories listed are certified by Centers for Medicare & Medicaid Service (CMS) CLIA Program

Overview

Methotrexate is a drug used to treat cancers and inflammatory diseases including rheumatoid arthritis, psoriasis, multiple sclerosis and Crohn’s disease. Some individuals are more sensitive to this drug and at high risk of toxicity, particularily certain Asian populations. Genetic testing can aid in identifying people with a high risk of toxicity when taking methotrexate. Follow the Read More button above to learn more.

Currently, this type of genetic testing is not readily available in Canada. Discuss this test with your physician to see if it could be beneficial for you.

Public Providers

Resources

Private Laboratories

*U.S. laboratories listed are certified by Centers for Medicare & Medicaid Service (CMS) CLIA Program

Overview

Methotrexate is a drug used to treat cancers and inflammatory diseases including rheumatoid arthritis, psoriasis, multiple sclerosis and Crohn’s disease. Some individuals are more sensitive to this drug and at high risk of toxicity, particularily certain Asian populations. Genetic testing can aid in identifying people with a high risk of toxicity when taking methotrexate. Follow the Read More button above to learn more.

Currently, this type of genetic testing is not readily available in Canada. Discuss this test with your physician to see if it could be beneficial for you.

Public Providers

Resources

Private Laboratories

*U.S. laboratories listed are certified by Centers for Medicare & Medicaid Service (CMS) CLIA Program

Overview

Methotrexate is a drug used to treat cancers and inflammatory diseases including rheumatoid arthritis, psoriasis, multiple sclerosis and Crohn’s disease. Some individuals are more sensitive to this drug and at high risk of toxicity, particularily certain Asian populations. Genetic testing can aid in identifying people with a high risk of toxicity when taking methotrexate. Follow the Read More button above to learn more.

Currently, this type of genetic testing is not readily available in Canada. Discuss this test with your physician to see if it could be beneficial for you.

Public Providers

Resources

Private Laboratories

*U.S. laboratories listed are certified by Centers for Medicare & Medicaid Service (CMS) CLIA Program

Overview

Methotrexate is a drug used to treat cancers and inflammatory diseases including rheumatoid arthritis, psoriasis, multiple sclerosis and Crohn’s disease. Some individuals are more sensitive to this drug and at high risk of toxicity, particularily certain Asian populations. Genetic testing can aid in identifying people with a high risk of toxicity when taking methotrexate. Follow the Read More button above to learn more.

Currently, this type of genetic testing is not readily available in Canada. Discuss this test with your physician to see if it could be beneficial for you.

Public Providers

Resources

Private Laboratories

*U.S. laboratories listed are certified by Centers for Medicare & Medicaid Service (CMS) CLIA Program

Overview

Methotrexate is a drug used to treat cancers and inflammatory diseases including rheumatoid arthritis, psoriasis, multiple sclerosis and Crohn’s disease. Some individuals are more sensitive to this drug and at high risk of toxicity, particularily certain Asian populations. Genetic testing can aid in identifying people with a high risk of toxicity when taking methotrexate. Follow the Read More button above to learn more.

Currently, this type of genetic testing is not readily available in Canada. Discuss this test with your physician to see if it could be beneficial for you.

Public Providers

Resources

Private Laboratories

*U.S. laboratories listed are certified by Centers for Medicare & Medicaid Service (CMS) CLIA Program

Overview

Methotrexate is a drug used to treat cancers and inflammatory diseases including rheumatoid arthritis, psoriasis, multiple sclerosis and Crohn’s disease. Some individuals are more sensitive to this drug and at high risk of toxicity, particularily certain Asian populations. Genetic testing can aid in identifying people with a high risk of toxicity when taking methotrexate. Follow the Read More button above to learn more.

Currently, this type of genetic testing is not readily available in Canada. Discuss this test with your physician to see if it could be beneficial for you.

Public Providers

Resources

Private Laboratories

*U.S. laboratories listed are certified by Centers for Medicare & Medicaid Service (CMS) CLIA Program

Overview

Methotrexate is a drug used to treat cancers and inflammatory diseases including rheumatoid arthritis, psoriasis, multiple sclerosis and Crohn’s disease. Some individuals are more sensitive to this drug and at high risk of toxicity, particularily certain Asian populations. Genetic testing can aid in identifying people with a high risk of toxicity when taking methotrexate. Follow the Read More button above to learn more.

Currently, this type of genetic testing is not readily available in Canada. Discuss this test with your physician to see if it could be beneficial for you.

Public Providers

Resources

Private Laboratories

*U.S. laboratories listed are certified by Centers for Medicare & Medicaid Service (CMS) CLIA Program